Gain expert insights in this interview on achieving transfection success. Explore proven strategies to optimize your approach ...

EQS-News: SARTORIUS AG / Key word (s): Quarter Results/Forecast Strong start to the year: Sartorius achieves significant profitable growth in the first quarter (news with additional features) 16.04 ...

Sartorius (0NIR – Research Report) received a Buy rating and a €270.00 price target from Deutsche Bank analyst Falko Friedrichs on April 17.

2025 Group EBITDA Margin Guidance: 29% to 30%. 2025 CapEx Ratio Guidance: Around 12.5%. Sartorius AG (SARTF) reported a strong start to 2025 with a 6.5% sales revenue growth in constant currencies.

Sartorius AG reported its first-quarter 2025 results, exceeding company-compiled consensus estimates. Sales and adjusted EBITDA increased in constant currency by 6.5% and 12.2%, respectively.

2025 Group EBITDA Margin Guidance: 29% to 30%. 2025 CapEx Ratio Guidance: Around 12.5%. Sartorius AG (SARTF) reported a strong start to 2025 with a 6.5% sales revenue growth in constant currencies.

German medical lab equipment maker Sartorius saw a jump in first-quarter net profit to €48.5 million ($55.2 million), up from ...

Please go ahead, sir. Thank you very much for the introduction, and hello, and welcome to our conference call on the Q1 results of Sartorius AG as well as Sartorius Stedim Biotech. Today ...

Thermo Fisher (TMO) stock and its peers gains as their EU rival Sartorius posts strong Q1 2025 resutls. Read more here.

Investing.com – Germany stocks were mixed after the close on Thursday, as gains in the Retail, Food & Beverages and Media sectors ...

Investing.com – Germany stocks were mixed after the close on Thursday, as gains in the Food & Beverages, Insurance and Retail ...

The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the mRNA synthesis and ...